Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
- Written by Reporters
New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatment
SINGAPORE - Media OutReach - 28 June 2023 – Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, today announced the official opening of its latest Good...Read more: Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore